As a Thematic Partner with Summa Equity, I work closely with the Changing Demographics team. Drawing on decades of executive leadership, commercial, and operational experience, I’m excited to contribute to Summa’s vision and passion for creating value in companies that can improve healthcare and life science research.
I serve as the Chair on G-Con Manufacturing and Axion Biosystems. In addition, I sit on the Sengenics Board and serve as Chair of the Renumeration Committee on Olink Proteomics Board. I’m excited to work with the talented teams at all these portfolio companies, who have great potential to solve critical global challenges within the life science and healthcare industry.
Before joining Summa Equity as a Partner, my career included roles as a senior executive in leading life science tools and diagnostics companies with a strong track record of successfully bringing new technologies to market and creating highly motivated teams poised to win.
Beyond Summa, I Chair the Board of Directors at Liderança Group, Inc, a SaaS company emphasizing tools to monitor a company’s journey through Diversity, Equity, and Inclusion. I remain active in the life sciences through engagements as a Board Member at SISCAPA Assay Technologies, Inc. and IROA Technologies, LLC. and the Advisory Board of Mobilion Systems, Inc.